Zymar® (gatifloxacin) is an eye drop approved for the treatment of conjunctivitis, which is more commonly known as "pink eye." It is used four to eight times a day, with a typical treatment length of seven days.
The medication is available by prescription only and is currently not available in generic form, even though the first patent for the drug has already expired. The manufacturer of brand-name Zymar is Allergan, Inc.
(To learn about side effects, warnings, and dosing for this drug, you can read the full-length article by clicking Zymar. This article also discusses how the eye drops work and why they may not be right for everyone.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Micromedex Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed November 19, 2010.
Gatifloxacin. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2009. Available from Wolters Kluwer Health, Inc. Accessed November 19, 2010.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed November 19, 2010.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed November 19, 2010.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed November 19, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click